Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples